BDBM218521 (r)-7-(4-chlorobenzyl)-6- ((1-cyclopropylethyl) amino)-8-(2-(3-((2- hydroxyethyl)amino)-3- oxopropoxy)-5- methylphenyl)-7h-purine- 2-carboxylic acid::US9540377, 4.12

SMILES C[C@@H](Nc1nc(nc2nc(-c3cc(C)ccc3OCCC(=O)NCCO)n(Cc3ccc(Cl)cc3)c12)C(O)=O)C1CC1

InChI Key InChIKey=RLEIOIUDLIVZBC-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 218521   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 218521BDBM218521(US9540377, 4.12 | (r)-7-(4-chlorobenzyl)-6- ((1-cy...)
Affinity DataIC50: 348nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent